BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN)

CUSIP: 09061G101

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock
Shares outstanding
192,975,286
Total 13F shares
181,117,177
Share change
-1,584,010
Total reported value
$12,795,609,480
Put/Call ratio
74%
Price per share
$70.69
Number of holders
576
Value change
-$83,582,224
Number of buys
334
Number of sells
221

Quarterly Holders Quick Answers

What is CUSIP 09061G101?
CUSIP 09061G101 identifies BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) as of Q1 2025

As of 31 Mar 2025, BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) was held by 576 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 181,117,177 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, PRIMECAP MANAGEMENT CO/CA/, Dodge & Cox, VIKING GLOBAL INVESTORS LP, Capital Research Global Investors, STATE STREET CORP, AMERIPRISE FINANCIAL INC, Elliott Investment Management L.P., and GEODE CAPITAL MANAGEMENT, LLC. This page lists 578 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.